You are here

NAFLD

A NASH player touts positive PhIII data, but true test still lies ahead

Endpoints

Mon, 01/31/22 - 11:04 am

clinical trials

Madrigal Pharmaceuticals

89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team

CP WIre

Fri, 08/9/19 - 08:11 pm

clinical trials

89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team

Fri, 08/9/19 - 08:10 pm

clinical trials

Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD

Yahoo

Thu, 03/5/15 - 08:49 am

SGLT2 inhibitor